CB Insights
Technology Market Intelligence
Technology Market Intelligence
Public list: Pharma Startups (4732) Cancer Therapeutics (1137)
EnGeneIC is an emerging biopharmaceutical company focused on developing its proprietary EDV nanocell platform for the targeted delivery of cancer therapeutic and other therapeutic molecules. The company's lead technology platform, EDV utilizes antib...Show all
Company (Alive / Active)
Phone: +612 9420 5844
25 Sirius Road, Lane Cove
Building 2
Lane Cove West, 2066
Australia
| Per Week | Per Month | Per 6 Months | Per Year | |
|---|---|---|---|---|
| Rank | Login to see details | |||
| Page Views Per Million | Login to see details | |||
| Page Views Per User | Login to see details | |||
| Reach Per Million | Login to see details | |||
| Investor | Investor Type | Location | Participating Rounds |
|---|
| Title | Application Date | Patent Date | Status (Patent / Application) |
|---|---|---|---|
| Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells | Jun 20, 2007 | Jan 30, 2018 | Patent |
| Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells | Apr 09, 2014 | Jan 16, 2018 | Patent |
| Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors | Dec 12, 2012 | Dec 19, 2017 | Patent |
| Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells | Dec 29, 2015 | Aug 15, 2017 | Patent |
| Combination tumor treatment with drug-loaded, bispecific ligand-targeted minicells and interferon-gamma | Oct 03, 2014 | Aug 15, 2017 | Patent |
Download PDF